Activated Notch1 Modulates Gene Expression in B Cells Similarly to Epstein-Barr Viral Nuclear Antigen 2

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2000 Jan 22

PMID 10644343

Citations 39

Authors

L J Strobl

H Hofelmayr

G Marschall

M Brielmeier

G W Bornkamm

U Zimber-Strobl

Affiliations

Soon will be listed here.

Abstract

Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch transactivate genes by interacting with the transcription factor RBP-Jkappa. The viral protein EBNA2 may hence be regarded as a functional equivalent of an activated Notch receptor. Until now, nothing has been known about the physiological role of Notch signaling in B cells. Here we investigated whether activated Notch can induce the same phenotypic changes as EBNA2 in Burkitt's lymphoma cells. An estrogen receptor fusion protein of the intracellular part of mouse Notch 1 (mNotch1-IC), mimicking in the presence of estrogen a constitutively active Notch receptor, was stably transfected into the Burkitt's lymphoma cell lines BL41-P3HR1 and HH514. Northern blot analysis revealed that the LMP2A gene is induced by Notch-IC in the presence of estrogen, whereas increased expression of LMP1 could be detected only if cycloheximide was simultaneously added. Concerning the cellular genes regulated by EBNA2, Notch-IC was able to upregulate CD21 but not CD23 expression. Immunoglobulin mu (Igmu) expression, which is downregulated by EBNA2, was also negatively regulated by Notch-IC. Similarly to EBNA2, Notch-IC was able to repress c-myc expression, which is under the control of the immunoglobulin heavy-chain locus in Burkitt's lymphoma cells with a t(8;14) translocation. The data show that Notch-IC is able to participate in gene regulation in B cells.

Citing Articles

How Epstein Barr Virus Causes Lymphomas.

Chiu Y, Ponlachantra K, Sugden B Viruses. 2024; 16(11).

PMID: 39599857 PMC: 11599019. DOI: 10.3390/v16111744.

EBV-associated diseases: Current therapeutics and emerging technologies.

Chakravorty S, Afzali B, Kazemian M Front Immunol. 2022; 13:1059133.

PMID: 36389670 PMC: 9647127. DOI: 10.3389/fimmu.2022.1059133.

Stromal Notch ligands foster lymphopenia-driven functional plasticity and homeostatic proliferation of naive B cells.

Gomez Atria D, Gaudette B, Londregan J, Kelly S, Perkey E, Allman A J Clin Invest. 2022; 132(13).

PMID: 35579963 PMC: 9246379. DOI: 10.1172/JCI158885.

Cancers associated with human gammaherpesviruses.

Wen K, Wang L, Menke J, Damania B FEBS J. 2021; 289(24):7631-7669.

PMID: 34536980 PMC: 9019786. DOI: 10.1111/febs.16206.

When Viruses Cross Developmental Pathways.

Trivedi P, Patel S, Bellavia D, Messina E, Palermo R, Ceccarelli S Front Cell Dev Biol. 2021; 9:691644.

PMID: 34422814 PMC: 8375270. DOI: 10.3389/fcell.2021.691644.

References

Hermeking H, Eick D . Mediation of c-Myc-induced apoptosis by p53. Science. 1994; 265(5181):2091-3. DOI: 10.1126/science.8091232. View

Lardelli M, Dahlstrand J, Lendahl U . The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium. Mech Dev. 1994; 46(2):123-36. DOI: 10.1016/0925-4773(94)90081-7. View

Swiatek P, Lindsell C, del Amo F, Weinmaster G, Gridley T . Notch1 is essential for postimplantation development in mice. Genes Dev. 1994; 8(6):707-19. DOI: 10.1101/gad.8.6.707. View

MEITINGER C, Strobl L, Marschall G, Bornkamm G, Zimber-Strobl U . Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element. J Virol. 1994; 68(11):7497-506. PMC: 237192. DOI: 10.1128/JVI.68.11.7497-7506.1994. View

Tedder T, Engel P . CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol Today. 1994; 15(9):450-4. DOI: 10.1016/0167-5699(94)90276-3. View

Kopan R, Nye J, Weintraub H . The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development. 1994; 120(9):2385-96. DOI: 10.1242/dev.120.9.2385. View

Nye J, Kopan R, Axel R . An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells. Development. 1994; 120(9):2421-30. DOI: 10.1242/dev.120.9.2421. View

Zimber-Strobl U, Strobl L, MEITINGER C, Hinrichs R, Sakai T, Furukawa T . Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. EMBO J. 1994; 13(20):4973-82. PMC: 395438. DOI: 10.1002/j.1460-2075.1994.tb06824.x. View

Johannsen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman S . Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J Virol. 1995; 69(1):253-62. PMC: 188571. DOI: 10.1128/JVI.69.1.253-262.1995. View

10.

Laux G, Adam B, Strobl L, Moreau-Gachelin F . The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. EMBO J. 1994; 13(23):5624-32. PMC: 395527. DOI: 10.1002/j.1460-2075.1994.tb06900.x. View

11.

Waltzer L, Logeat F, Brou C, Israel A, Sergeant A, Manet E . The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J. 1994; 13(23):5633-8. PMC: 395528. DOI: 10.1002/j.1460-2075.1994.tb06901.x. View

12.

Ling P, Rawlins D, Hayward S . The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc Natl Acad Sci U S A. 1993; 90(20):9237-41. PMC: 47542. DOI: 10.1073/pnas.90.20.9237. View

13.

Fortini M, Artavanis-Tsakonas S . Notch: neurogenesis is only part of the picture. Cell. 1993; 75(7):1245-7. DOI: 10.1016/0092-8674(93)90611-s. View

14.

Artavanis-Tsakonas S, Matsuno K, Fortini M . Notch signaling. Science. 1995; 268(5208):225-32. DOI: 10.1126/science.7716513. View

15.

Jochner N, Eick D, Zimber-Strobl U, Pawlita M, Bornkamm G, Kempkes B . Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. EMBO J. 1996; 15(2):375-82. PMC: 449952. View

16.

Hsieh J, Henkel T, Salmon P, Robey E, Peterson M, Hayward S . Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol. 1996; 16(3):952-9. PMC: 231077. DOI: 10.1128/MCB.16.3.952. View

17.

Kopan R, Schroeter E, Weintraub H, Nye J . Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci U S A. 1996; 93(4):1683-8. PMC: 40002. DOI: 10.1073/pnas.93.4.1683. View

18.

Kempkes B, Zimber-Strobl U, Eissner G, Pawlita M, Falk M, Hammerschmidt W . Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines. J Gen Virol. 1996; 77 ( Pt 2 ):227-37. DOI: 10.1099/0022-1317-77-2-227. View

19.

Cohen J, Wang F, MANNICK J, Kieff E . Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci U S A. 1989; 86(23):9558-62. PMC: 298536. DOI: 10.1073/pnas.86.23.9558. View

20.

Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O . Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J Virol. 1990; 64(3):1002-13. PMC: 249210. DOI: 10.1128/JVI.64.3.1002-1013.1990. View